Published by Josh White on 7th April 2020
(Sharecast News) - Cell-based therapeutics company ReNeuron Group has signed a research agreement with an unnamed major pharmaceutical company, it announced on Tuesday, to explore the potential use of its proprietary exosomes to deliver novel therapeutics.
URL: http://www.digitallook.com/dl/news/story/30502647/...